{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:54:06Z","timestamp":1761519246641,"version":"build-2065373602"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.maturitas.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T12:26:24Z","timestamp":1544012784000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Insulin resistance and adrenal incidentalomas: A bidirectional relationship"],"prefix":"10.1016","volume":"121","author":[{"given":"Guy I.","family":"Sydney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi J.","family":"Ioakim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-1376","authenticated-orcid":false,"given":"Stavroula A.","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2018.12.002_bib0005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0002-9610(85)80186-0","article-title":"Serendipitous adrenal masses: prevalence, significance, and management","volume":"149","author":"Abecassis","year":"1985","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0010","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF03344099","article-title":"Prevalence of adrenal incidentaloma in a contemporary computerized tomography series","volume":"29","author":"Bovio","year":"2006","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archsurg.1994.01420270067016","article-title":"Subclinical hormone secretion by incidentally discovered adrenal masses","volume":"129","author":"Caplan","year":"1994","journal-title":"Arch. Surg."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0020","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study","author":"Ng","year":"2013","journal-title":"The Lancet [Intranet]"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.maturitas.2016.07.017","article-title":"Adrenal incidentalomas: a guide to assessment, treatment and follow-up","volume":"92","author":"Paschou","year":"2016","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.maturitas.2018.12.002_bib0030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0035","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00268-005-0681-x","article-title":"Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery","volume":"30","author":"Erbil","year":"2006","journal-title":"World J. Surg."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0040","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1210\/jc.2002-020399","article-title":"Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism","volume":"87","author":"Chiodini","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0045","first-page":"1440","article-title":"Subclinical Cushing\u2019s syndrome in patients with adrenal incidentaloma: clinical and biochemical features","volume":"85","author":"Rossi","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0050","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jcem.87.3.8277","article-title":"Adrenal incidentaloma: a new cause of the metabolic syndrome?","volume":"87","author":"Terzolo","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0055","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1210\/jc.2001-011766","article-title":"Patients with subclinical Cushing\u2019s syndrome due to adrenal adenoma have increased cardiovascular risk","volume":"87","author":"Tauchmanova","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2018.12.002_bib0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1478-7954-10-22","article-title":"National, regional, and global trends in adult overweight and obesity prevalences","volume":"10","author":"Stevens","year":"2012","journal-title":"Popul. Health Metr."},{"issue":"3","key":"10.1016\/j.maturitas.2018.12.002_bib0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.diabres.2010.04.012","article-title":"The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies","volume":"89","author":"Abdullah","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0070","unstructured":"National Diabetes Information Clearinghouse, US Department of Health and Human Services Diabetes Fact Sheet. http:\/\/diabetes.niddk.nih.gov\/dm\/pubs\/overview\/. (Accessed 21 April 2018)."},{"issue":"3","key":"10.1016\/j.maturitas.2018.12.002_bib0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cdp.2008.08.004","article-title":"Estimating the number of U.S. Incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers","volume":"32","author":"Polednak","year":"2008","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0080","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0085","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7326\/0003-4819-138-5-200303040-00013","article-title":"Management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d)","volume":"138","author":"Grumbach","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/eje.0.1490273","article-title":"Prevalence and natural history of adrenal incidentalomas","volume":"149","author":"Barzon","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0095","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0100","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A core gut microbiome in obese and lean twins","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0105","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1073\/pnas.1116053109","article-title":"Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease","volume":"109","author":"Greenblum","year":"2012","journal-title":"Proc Natl Acad Sci."},{"issue":"9","key":"10.1016\/j.maturitas.2018.12.002_bib0110","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.297.9.969","article-title":"Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women<SUBTITLE>The A TO Z weight loss study: a randomized trial<\/SUBTITLE>","volume":"297","author":"Gardner","year":"2007","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.maturitas.2018.12.002_bib0115","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.1073\/pnas.0903103106","article-title":"Potential etiologic and functional implications of genome-wide association loci for human diseases and traits","volume":"106","author":"Hindorff","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.maturitas.2018.12.002_bib0120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ng.686","article-title":"Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index","volume":"42","author":"Speliotes","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0125","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1073\/pnas.91.11.4854","article-title":"Tumor necrosis factor-\u03b1 inhibits signaling from the insulin receptor","volume":"91","author":"Hotamisligil","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.maturitas.2018.12.002_bib0130","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.maturitas.2018.12.002_bib0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bpg.2014.07.007","article-title":"The risk of colonic adenomas and colonic cancer in obesity","volume":"28","author":"Laiyemo","year":"2014","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0140","first-page":"83","article-title":"Immunoreactivity and receptor expression of insulin-like growth factor I and insulin in human adrenal tumors. An immunohistochemical study of 94 cases","volume":"138","author":"Kamio","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0145","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/endo-122-6-2518","article-title":"Characterization of insulin\u2010like growth factor I and insulin receptors on cultured bovine adrenal fasciculata cells. Role of these peptides on adrenal cell function","volume":"122","author":"Penhoat","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0150","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0006-291X(89)91055-3","article-title":"Receptors for insulin and insulin\u2010like growth factor\u2010I in the human adrenal gland","volume":"165","author":"Pillion","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0155","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1530\/eje.0.1360296","article-title":"Insulin\u2010like growth factor receptors in normal and tumorous adult human adrenocortical glands","volume":"136","author":"Weber","year":"1997","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0160","first-page":"968","article-title":"Mitogenic action, regulation, and localization of insulin\u2010like growth factors in the human fetal adrenal gland","volume":"76","author":"Mesiano","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/dna.1988.7.9","article-title":"Developmental and hormonal regulation of mRNAs for insulin\u2010like growth factor II and steroidogenic enzymes in human fetal adrenals and gonads","volume":"7","author":"Voutilainen","year":"1988","journal-title":"DNA"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2011.09.042","article-title":"Insulin\u2010like growth factor system on adrenocortical tumorigenesis","volume":"351","author":"Ribeiro","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0175","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1210\/jc.2008-0065","article-title":"Expression of insulin\u2010like growth factor\u2010II and its receptor in pediatric and adult adrenocortical tumors","volume":"93","author":"Almeida","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0180","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-08-1067","article-title":"Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling","volume":"15","author":"Giordano","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0185","doi-asserted-by":"crossref","first-page":"e73959","DOI":"10.1371\/journal.pone.0073959","article-title":"Single nucleotide polymorphism array profiling of adrenocortical tumors\u2014evidence for an adenoma carcinoma sequence?","volume":"8","author":"Ronchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0190","doi-asserted-by":"crossref","first-page":"e44171","DOI":"10.1371\/journal.pone.0044171","article-title":"Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models","volume":"7","author":"Drelon","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0195","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ajpath.2012.05.026","article-title":"Progression to adrenocortical tumorigenesis in mice and humans through insulin\u2010like growth factor 2 and \u03b2\u2010catenin","volume":"181","author":"Heaton","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0200","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1210\/endo.140.4.6660","article-title":"Postnatal overexpression of insulin\u2010like growth factor II in transgenic mice is associated with adrenocortical hyperplasia and enhanced steroidogenesis","volume":"140","author":"Weber","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1096-6374(98)80110-X","article-title":"What is the function of IGF\u2010II in postnatal life? Answers from transgenic mouse models","volume":"8","author":"Wolf","year":"1998","journal-title":"Growth Horm. IGF Res."},{"issue":"12","key":"10.1016\/j.maturitas.2018.12.002_bib0210","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/ijc.29950","article-title":"Adrenocortical tumors and insulin resistance: what is the first step?","volume":"138","author":"Altieri","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0215","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/er.2008-0047","article-title":"Insulin receptor isoforms and insulin receptor\/insulin\u2010like growth factor receptor hybrids in physiology and disease","volume":"30","author":"Belfiore","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0220","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1128\/MCB.19.10.7203","article-title":"Multiple signaling pathways of the insulin\u2010like growth factor 1 receptor in protection from apoptosis","volume":"19","author":"Peruzzi","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0225","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tem.2011.12.007","article-title":"Insulin signaling\u2014mathematical modeling comes of age","volume":"23","author":"Nyman","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0230","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1749-6632.1995.tb26690.x","article-title":"Mitogenic potential of insulin on lymphoma cells lacking IGF\u20101 receptor","volume":"766","author":"Ish\u2010Shalom","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0235","doi-asserted-by":"crossref","first-page":"22231","DOI":"10.1016\/S0021-9258(18)41513-X","article-title":"Functional expression of insulin receptor substrate\u20101 is required for insulin\u2010stimulated mitogenic signaling","volume":"268","author":"Waters","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0240","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0245","first-page":"4712","article-title":"Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation","volume":"85","author":"Leung","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0250","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI114868","article-title":"Elevated insulin receptor content in human breast cancer","volume":"86","author":"Papa","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0255","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0889-8529(05)70122-5","article-title":"Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota","volume":"29","author":"Young","year":"2000","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"6","key":"10.1016\/j.maturitas.2018.12.002_bib0260","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1210\/en.2016-1804","article-title":"Adrenal mass: insight into pathogenesis and a common link with insulin resistance","volume":"158","author":"Muscogiuri","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0265","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/07435809609043773","article-title":"Adrenal incidentalomas: a manifestation of the metabolic syndrome?","volume":"22","author":"Reincke","year":"1996","journal-title":"Endocr. Res."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0270","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1365-2265.2001.01274.x","article-title":"The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection","volume":"54","author":"Midorikawa","year":"2001","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"3","key":"10.1016\/j.maturitas.2018.12.002_bib0275","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2265.2010.03928.x","article-title":"The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?","volume":"74","author":"Muscogiuri","year":"2011","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0280","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1758-5996-2-71","article-title":"Prevalence of adrenal masses in Japanese patients with type 2 diabetes mellitus","volume":"2","author":"Hiroi","year":"2010","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0285","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.0954-6820.1968.tb02445.x","article-title":"On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes","volume":"184","author":"Hedeland","year":"1968","journal-title":"Acta Med. Scand."},{"issue":"1","key":"10.1016\/j.maturitas.2018.12.002_bib0290","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2265.1998.00437.x","article-title":"Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma","volume":"49","author":"Fern\u00e1ndez-Real","year":"1998","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.numecd.2005.10.013","article-title":"Obesity and cancer","volume":"16","author":"Vigneri","year":"2006","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0300","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","article-title":"Increased cancer\u2010related mortality for patients with type 2 diabetes who use sulfonylureas or insulin","volume":"29","author":"Bowker","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0305","first-page":"1939","article-title":"Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression","volume":"53","author":"Wu","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0310","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/dc12-0002","article-title":"Diabetes and cause\u2010specific mortality in a prospective cohort of one million U.S. adults","volume":"35","author":"Campbell","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0315","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00125-006-0207-6","article-title":"Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria","volume":"49","author":"Rapp","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0320","doi-asserted-by":"crossref","first-page":"461917","DOI":"10.1155\/2014\/461917","article-title":"Hyperglycemia, a neglected factor during cancer progression","volume":"2014","author":"Duan","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0325","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.10421","article-title":"Metformin as a new anti-cancer drug in adrenocortical carcinoma","author":"Poli","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0330","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/ERC-09-0170","article-title":"Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model","volume":"17","author":"Luconi","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0335","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0960-9822(01)00225-1","article-title":"Tumor suppressor and anti-inflammatory actions of PPAR-gamma agonists are mediated via upregulation of PTEN","volume":"11","author":"Patel","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0340","doi-asserted-by":"crossref","first-page":"904041","DOI":"10.1155\/2008\/904041","article-title":"Rosiglitazone inhibits adrenocortical cancer cell proliferation by interfering with the IGF\u2010IR intracellular signaling","volume":"2008","author":"Cantini","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0345","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1210\/jc.2004-1267","article-title":"Peroxisome proliferator\u2010activated receptor\u2010gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation","volume":"90","author":"Betz","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0350","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1210\/jc.2004-0978","article-title":"Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R","volume":"90","author":"Ferruzzi","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0355","first-page":"429","article-title":"Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk","volume":"9","author":"Zou","year":"2013","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0360","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mce.2014.07.007","article-title":"The effect of pioglitazone on aldosterone and cortisol production in HAC15 human adrenocortical carcinoma cells","volume":"394","author":"Pan","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0365","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2214\/ajr.139.1.81","article-title":"Nonfunctioning adrenal masses: incidental discovery on computed tomography","volume":"139","author":"Glazer","year":"1982","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0370","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.1982.03330060041031","article-title":"Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required?","volume":"248","author":"Prinz","year":"1982","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0375","first-page":"203","article-title":"Incidentally discovered mass of the adrenal gland","volume":"163","author":"Belldegrun","year":"1986","journal-title":"Surg. Gynecol. Obstet."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0380","first-page":"1014","article-title":"Incidentally discovered adrenal tumors: an institutional perspective","volume":"110","author":"Herrera","year":"1991","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.maturitas.2018.12.002_bib0385","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/eje.0.1490273","article-title":"Prevalence and natural history of adrenal incidentalomas","volume":"149","author":"Barzon","year":"2003","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.maturitas.2018.12.002_bib0390","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12020-015-0776-6","article-title":"Subclinical Cushing\u2019s syndrome in patients with bilateral compared to unilateral adrenal incidentalomas: a systematic review and meta-analysis","volume":"51","author":"Paschou","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0395","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/jclinpath-2014-202612","article-title":"Clinicopathological correlates of adrenal Cushing\u2019s syndrome","volume":"68","author":"Duan","year":"2015","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0400","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1710990102","article-title":"Adrenocortical nodular hyperplasia: the ageing adrenal","volume":"99","author":"Dobbie","year":"1969","journal-title":"J. Pathol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0410","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0889-8529(18)30082-3","article-title":"Epidemiology of Cushing\u2019s syndrome and subclinical disease","volume":"23","author":"Ross","year":"1994","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0415","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.0.1460061","article-title":"Development of overt Cushing\u2019s syndrome in patients with adrenal incidentaloma","volume":"146","author":"Barzon","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0420","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1677\/joe.0.1370213","article-title":"The effects of cortisol on hepatic and renal gluconeogenic enzyme activities in the sheep fetus during late gestation","volume":"137","author":"Fowden","year":"1993","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052363","article-title":"Effects of cortisol and dexamethasone on insulin signalling pathways in skeletal muscle of the ovine fetus during late gestation","volume":"7","author":"Jellyman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0430","article-title":"Glucagon\u2010cortisol interactions on glucose turnover and lactate gluconeogenesis in normal humans","volume":"258","author":"Lecavalier","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0435","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1530\/EJE-09-1034","article-title":"Acute and 2\u2010week exposure to prednisolone impair different aspects of beta\u2010cell function in healthy men","volume":"162","author":"van Raalte","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.maturitas.2018.12.002_bib0440","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2265.1998.00437.x","article-title":"Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours","volume":"49","author":"Fernandez-Real","year":"1998","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.maturitas.2018.12.002_bib0445","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1210\/jcem.79.6.7989452","article-title":"Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)","volume":"79","author":"Osella","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512218306777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512218306777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:12:57Z","timestamp":1759914777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512218306777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":89,"alternative-id":["S0378512218306777"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2018.12.002","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin resistance and adrenal incidentalomas: A bidirectional relationship","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}